Creating vaccines to combat E. coli and other infectious diseases
Task V09: Development and Manufacture of Toxoid Fusion Master Banks
['FUNDING_OTHER'] · IDT BIOLOGIKA GMBH · NIH-10268398
This study is working on creating new vaccines to help protect people from infections caused by E. coli, which could be especially helpful for patients looking for better ways to stay healthy and safe from serious illnesses.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | IDT BIOLOGIKA GMBH (nih funded) |
| Locations | 1 site (DESSAU-ROSSLAU, GERMANY) |
| Trial ID | NIH-10268398 on ClinicalTrials.gov |
What this research studies
This research focuses on the development and manufacturing of vaccines and biologics aimed at preventing infectious diseases, particularly those caused by E. coli. It involves planning, optimizing, and producing vaccine candidates in compliance with regulatory standards for clinical trials. Patients may benefit from the introduction of new vaccines that could protect against serious infections and bioterrorism threats. The research includes comprehensive support for regulatory submissions to ensure safety and efficacy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of E. coli infections or those in populations vulnerable to emerging infectious diseases.
Not a fit: Patients who are not at risk for E. coli infections or those who have already been vaccinated against the targeted pathogens may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that protect patients from E. coli infections and other infectious diseases.
How similar studies have performed: Previous research has shown success in developing vaccines for infectious diseases, indicating a promising potential for this approach.
Where this research is happening
DESSAU-ROSSLAU, GERMANY
- IDT BIOLOGIKA GMBH — DESSAU-ROSSLAU, GERMANY (ACTIVE)
Researchers
- Principal investigator: NEUBERT, ANDREAS — IDT BIOLOGIKA GMBH
- Study coordinator: NEUBERT, ANDREAS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Communicable Diseases, Infectious Disease Pathway, Infectious Diseases, Infectious Disorder